- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - AstraZeneca PLC - US court decision favours Symbicort patents
AnnouncementREG - AstraZeneca PLC - Further update on roxadustat US regulatory review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Voluntary withdrawal Imfinzi US bladder indication
AnnouncementREG - AstraZeneca PLC - Lynparza: IDMC recommend early analysis of OlympiA
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - AstraZeneca Non-Executive Board changes
AnnouncementREG - AstraZeneca PLC - AZN: full-year 2020 results
AnnouncementREG - AstraZeneca PLC - Divestment of Crestor in Europe completed
AnnouncementREG - AstraZeneca PLC - Update on KESTREL Phase III trial for Imfinzi
AnnouncementREG - AstraZeneca PLC - Forxiga approved in China for heart failure
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca agrees to divest Viela shareholding
AnnouncementREG - AstraZeneca PLC - COVID-19 vaccine authorised for use by the EU
AnnouncementREG - AstraZeneca PLC - COVID-19 vaccine receives positive opinion in EU
AnnouncementREG - AstraZeneca PLC - Block listing application
Announcement